← SynDRA
CTS-1027
SynDRA canonical compound SYN0003326 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | MMP13 |
|---|
| Mechanism of action | Metalloproteinase inhibitor |
|---|
All known targets
- MMP13
- MMP2
- MMP3
- MMP9
- MMP1
- MMP12
- MMP14
- MMP8
Mechanisms of action (all sources)
- Metalloproteinase inhibitor
- MMP3 INHIBITOR
- Matrix metalloproteinase 3 inhibitor
- MMP14 INHIBITOR
- Matrix metalloproteinase 14 inhibitor
- MMP8 INHIBITOR
- Matrix metalloproteinase 8 inhibitor
- MMP9 INHIBITOR
- Matrix metalloproteinase 9 inhibitor
- MMP12 INHIBITOR
- Matrix metalloproteinase 12 inhibitor
- MMP13 INHIBITOR
Cross-references
Synonyms
- RO-1130830
- RS-130830
- CTS 1027
- UNII-2QD3F58224
- CHEMBL440498
- 2QD3F58224
- 4-[4-(4-CHLORO-PHENOXY)-BENZENESULFONYLMETHYL]-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HYDROXYAMIDE
- 4-[[[4-(4-Chlorophenoxy)phenyl]sulfonyl]methyl]tetrahydro-N-hydroxy-2H-pyran-4-carboxamide
- 4-(4-(4-Chloro-phenoxy)-benzenesulfonylmethyl)-tetrahydro-pyran-4-carboxylic acid hydroxyamide
- Ro-1130830
- AC1MOE9A
- SCHEMBL2381112
- BDBM11863
- DTXSID90172907
- 830c
- ZINC1488366
- BCP13018
- 3563AH
- alpha-tetrahydropyran beta-sulfone 1B
- AKOS030526690
- RS 130830
- RefChem:579508
- DTXCID4095398
- Ro 1130830;RS 130830
- orb1707421
- GLXC-06232
- THA02204
- MFCD16657131
- CS-0281
- HY-10398
- MS-27506
- DB-114312
- NS00068484
- RS-130,830
- F83499
- T15015
- BRD-K53508936-001-01-0
Look up CTS-1027 in the interactive SynDRA portal →